Sinogen Biopharma

Boston, United States

Sinogen Biopharma is a developer of innovative drugs with a vision to bridge China's biotech innovation to the US pharma market.

Dec 2023

Series B

Biopharma Biotechnology Health Care Medical Pharmaceutical

Top Investors

Qiming Venture Partners Westlake Village BioPartners CHERAMI Puxin Capital Winzac Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sinogen Biopharma

Who are Sinogen Biopharma's investors?

Sinogen Biopharma's investors include Qiming Venture Partners, Westlake Village BioPartners, CHERAMI, Puxin Capital, Winzac Capital.

Where is Sinogen Biopharma headquartered?

Sinogen Biopharma is headquartered in Boston, United States.

What does Sinogen Biopharma do?

Sinogen Biopharma is a developer of innovative drugs with a vision to bridge China's biotech innovation to the US pharma market.

What stage is Sinogen Biopharma at?

Sinogen Biopharma is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 30, 2023.

MLA

"Sinogen Biopharma — Funding & Investors." VCBacked, December 30, 2023, https://www.vcbacked.co/company/sinogen-biopharma. Accessed July 4, 2026.

APA

VCBacked. (2023). Sinogen Biopharma — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/sinogen-biopharma

Wikipedia (cite web)

{{cite web |title=Sinogen Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/sinogen-biopharma |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 30, 2023.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.